Company Overview and News


Add ALNEV
to your dashboard

Headline News

Colorectal Cancer Pipeline 2016 Global Market Review Covering 227 Companies

2016-08-10 prnewswire
RnRMarketResearch.com adds "Colorectal Cancer - Pipeline Review, H1 2016" market research report to its store providing an overview and comprehensive information on the therapeutic development for Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Age Related Macular Degeneration Pipeline Landscape and Therapeutics Market 2016 Review

2016-07-08 prnewswire
RnRMarketResearch.com adds "Age Related Macular Degeneration - Pipeline Review, H1 2016" offering information on comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Age Related Macular Degeneration and special features on late-stage and discontinued projects.

Stellar Biotechnologies: Vaccine Tech Buoyed By Partnerships

2016-06-23 seekingalpha
Stellar has undisclosed partners working in Alzheimer's disease, as well as other undisclosed oncology and autoimmune indications.

Pipeline of Psoriasis Market Covering 140 Companies Reviewed for H1 2016

2016-05-13 prnewswire
RnRMarketResearch.com adds "Psoriasis - Pipeline Review, H1 2016" market research report that provides an overview of the Psoriasis's therapeutic pipeline with comprehensive information and comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Pipeline of Systemic Lupus Erythematosus Market Reviewed for H2 2015 in New Research Report

2016-02-18 prnewswire
PUNE, India, February 18, 2016 /PRNewswire/ -- New market research titled

Stellar Biotechnologies and Neovacs Propose to Form Joint Venture to Manufacture Conjugated Therapeutic Vaccines With Stellar KLH(TM)

2016-01-20 marketwired
PORT HUENEME, CA and PARIS, FRANCE and BOSTON, MA--(Marketwired - Jan 20, 2016) - Stellar Biotechnologies, Inc. ("Stellar") (NASDAQ: SBOT) (TSX VENTURE: KLH) and Neovacs S.A. ("Neovacs") (ALTERNEXT PARIS: ALNEV) today announced they have entered into a term sheet to form a joint venture for the manufacture of conjugated therapeutic...